Akèy › Maladi Entestinal Anflamatwa › New York › New York City
Etid klinik pou Maladi Entestinal Anflamatwa nan New York City, NY
18 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Pioneer Clinical Research NY, New York
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Ap rekriteFaz 2
- Site 037, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Ap rekriteFaz 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Ap rekriteFaz 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Ap rekriteFaz 3
- Weill Cornell Medicine, New York
BOOM-IBD2 Pivotal Clinical Trial
Ap rekrite
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Icahn School of Medicine at Mount Sinai, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Ap rekriteEtid obsèvasyon
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
Ap rekriteFaz 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
Ap rekriteFaz 2
- Icahn School of Medicine at Mount Sinai, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
Ap rekriteFaz 4
- Columbia University Medical Center, New York
Impact of Morning Light Therapy in IBD
Ap rekrite
- Mount Sinai Hospital, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, New York
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Ap rekrite
- NYU Langone Health, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Icahn School of Medicine at Mount Sinai, New York
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Ap rekriteEtid obsèvasyon
- New York University, New York
Etid Maladi Entestinal Anflamatwa nan lòt vil
- Boston, MA15 etid
- Miami, FL9 etid
- Seattle, WA9 etid
- Durham, NC8 etid
- Atlanta, GA8 etid
- Houston, TX8 etid
- Orlando, FL8 etid
- Washington, DC7 etid
- Philadelphia, PA7 etid
- St. Louis, MO7 etid
- Cincinnati, OH7 etid
- Baltimore, MD6 etid
Lòt etid nan New York City
- Kansè nan tete136 etid
- Kansè Poumon ki pa ti selil121 etid
- Kansè (tout kalite)109 etid
- Kansè pwostat103 etid
- Kansè Metastatik93 etid
- Kansè kolorektal78 etid
- Kansè ovè69 etid
- Kansè poumon60 etid
- Myelom Miltip60 etid
- Kansè pankreyas60 etid
- Kansè Endomèt52 etid
- Leksemi mieloïd egi51 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.